The ratio n-6/n-3 PUFA exerts a significant impact on the treatment of colon and liver cancer by reducing cyclooxygenase-2 (COX-2), the number of adenocarcinomas, and TNF-α. Here, PTGS2 is linked to adenocarcinoma.